Therapy Areas: Oncology
Leo Cancer Care invests in children's experience of radiotherapy, following world-first treatments
28 September 2026 - Radiotherapy technology company Leo Cancer Care on Sunday announced plans to further invest in the treatment experience for children undergoing radiation therapy.Following the worl...
Innovent expands global Phase 3 study of IBI363/TAK-928 to include non-squamous NSCLC
28 September 2026 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX:01801) announced on Sunday an expansion of the global Phase 3 MarsLight-11 trial, which is evaluating IBI363 (Takeda ...
Akeso enrols first patient in global Phase III trial of cadonilimab vs nivolumab in first-line gastric cancer
28 September 2026 - Chinese pharmaceutical company Akeso Inc (HK:9926) announced on Sunday that the first patient has been enrolled in COMPASSION-37 (AK104-311), a global, multicentre Phase III head-t...
FDA approves WELIREG and LENVIMA combination for previously treated advanced renal cell carcinoma
25 September 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, and its Japanese partner Eisai Co Ltd (TYO:4523) announced on Friday that the US Fo...
AstraZeneca's IMFINZI combination receives US Priority Review for muscle-invasive bladder cancer
25 September 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) announced on Friday that the US Food and Drug Administration (FDA) has accepted and granted Priority Review...
UChicago Medicine completes construction phase of new cancer facility
25 September 2026 - The University of Chicago Medicine announced on Thursday the completion of the construction phase of the AbbVie Foundation Cancer Pavilion.Scheduled to open in April 2027 on UChica...